首页 | 官方网站   微博 | 高级检索  
     

台湾地区医保药品的采购模式和支付价格
引用本文:王雅楠,官海静,刘国恩,孙利华.台湾地区医保药品的采购模式和支付价格[J].中国卫生政策研究,2015,8(12):18-22.
作者姓名:王雅楠  官海静  刘国恩  孙利华
作者单位:沈阳药科大学工商管理学院 辽宁沈阳 110016
摘    要:目的:分析台湾地区医保药品在采购和支付方面的做法和经验,为大陆地区推进药品采购模式和支付价格改革提供参考。方法:系统梳理台湾地区在医保药品采购和支付方面的政策文件和相关文献,并与大陆地区药品采购和支付政策进行对比分析。结果:台湾地区医疗机构根据自身用药需求,自主采购药品,采购价格由供需双方直接谈判形成。政府仅对医保药品的价格进行管理,对新药采用国际参考定价办法;原厂药、BA/BE学名药、一般学名药的支付价以国际参考价格为上限,依次降低。药品质量也在医保支付标准考虑之列。此外,药品的支付价格依据采购价格实行动态调整,当二者差值大于30%时,健保署便会调整支付价格以减小二者的差价。结论:台湾地区通过制度设计和调整,较好地统筹了药品采购和补偿两个环节,形成了合理的药品采购价格和支付价格,这些经验可为中国大陆地区完善药品采购和支付政策提供参考。

关 键 词:台湾地区  药品采购模式  医保支付价格  药品支付价格
收稿时间:2015/8/11 0:00:00
修稿时间:2015/11/12 0:00:00

Pharmaceutical procurement and reimbursement schedule in Taiwan
WANG Ya-nan,GUAN Hai-jing,LIU Guo-en,SUN Li-hua.Pharmaceutical procurement and reimbursement schedule in Taiwan[J].Chinese Journal of Health Policy,2015,8(12):18-22.
Authors:WANG Ya-nan  GUAN Hai-jing  LIU Guo-en  SUN Li-hua
Affiliation:School of Business Administration, Shenyang Pharmaceutical University, Shenyang Liaoning 110016, China
Abstract:Object: The paper aims to analyze Taiwanese experience in pharmaceutical procurement, pharmaceutical benefits and reimbursement schedule, and make references for the Mainland China. Methods: Through reading and analyzing the Taiwanese government policy and the literature published to find out the pharmaceutical procurement measures, different medicines' pricing strategy and its reimbursement mode compared with the Mainland China. Results: Hospitals can purchase medicines based on their own needs, and the purchase price was formed through negotiating with providers and buyers. It has been found that Taiwan only controls the medicines reimbursement prices. The international reference pricing is adopted for new medicines, and the originators, bioequivalence/bioavailability generic medicines and general generics reimbursement prices are very high at international reference prices, and need to be weakened in order to fit the requirements. Moreover, the medicine quality is one of the standards considered in case of making decisions on the reimbursement prices. In addition, the reimbursement price is associated with procurement price. When the spread is larger than 30%, the government will adjust the reimbursement to fill the gap. Conclusions: Through the system design and adjustment, the Taiwanese Government have set up a better procurement and reimbursement co-ordination in the pharmaceutical segment, and formed the reasonable prices for the case. The Taiwanese experience can be taken as a reference for the mainland China to refine its procurement reforms and reimbursement policy.
Keywords:Taiwan  Pharmaceutical procurement model  Medical insurance payment price  Pharmaceutical reimbursement price
本文献已被 CNKI 等数据库收录!
点击此处可从《中国卫生政策研究》浏览原始摘要信息
点击此处可从《中国卫生政策研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号